Ukwelashwa Komdlavuza Wamaphaphu ngeSigaba 2026: I-China Guide & Cost – Izibhedlela Eziseduze Nami 

Ukwelashwa komdlavuza wamaphaphu ngesigaba ngo-2026 kubhekiselwa kumigomo ejwayelekile, esekwe ebufakazini esetshenziswa eChina ukuphatha umdlavuza wamaphaphu oyinhloko ngokuya ngezinga lokusabalala kwawo. Okwakamuva 2026 Izinkombandlela Zokwelashwa KwaseShayina gcizelela ukushintshela ekwelashweni okunembayo, okuhlanganisa izindlela zokwelapha ezihlosiwe zamangqamuzana kanye nokwelashwa kwamasosha omzimba kanye nokwelashwa ngamakhemikhali okungokwesiko nemisebe. Ezifweni eziqala ukuvela, ukuhlinzwa kuhlala kwelapha, kuyilapho abaphathi beSigaba IV manje sebebeka phambili ukuphrofayilisa ngezakhi zofuzo ukuze bakhethe ukwelashwa okuhlelekile okufanelekile, okunweba kakhulu ukuphila kanye nokwenza ngcono izinga lempilo yezigidi zeziguli.

Ukuqonda i-Lung Cancer Staging ngo-2026

Isiteji esinembayo siyisisekelo sokusebenza ngempumelelo ukwelashwa komdlavuza wamaphaphu ngesiteji. Ngo-2026, izazi ze-oncologists zaseShayina zibambelela ngokuqinile kuHlelo lwesi-9 lohlelo lwesiteji lwe-TNM olusungulwe yi-International Association for the Study of Lung Cancer (IASLC). Lolu hlelo luhlukanisa izimila ngokusekelwe kusayizi (T), ukubandakanyeka kwe-lymph node (N), kanye ne-metastasis ekude (M). Ukuqonda lezi zigaba kubalulekile ngoba amasu okwelapha ahluka kakhulu phakathi kokukhula kwendawo kanye nezifo ezisabalele.

Isimo somdlavuza wamaphaphu eChina sisalokhu siyinselele. Idatha evela ku-National Cancer Center ikhombisa ukuthi umdlavuza wamaphaphu uyithumba eliyingozi elidlange kakhulu, cishe nezigidi eziyi-1.06 zezehlakalo ezintsha kanye nokufa kwabantu abangu-733,300 ngo-2022. Naphezu kokwanda kokuqwashisa umphakathi mayelana nokuhlolwa, ingxenye enkulu yeziguli itholakala eSigabeni IV. Ngenxa yalokho, i- 2026 imihlahlandlela gxila kakhulu ekuthuthukiseni imiphumela yezifo ezithuthukisiwe kuyilapho uqinisa izinqubo zokutholwa kusenesikhathi.

I-Shift to Precision Medicine

Incazelo yokunakekelwa okujwayelekile isishintshile. Ngenkathi i-chemotherapy ike yaba ukuphela komgogodla wokwelapha, isibuyekezo sango-2026 siyakubona lokho ukwelapha okuhlosiwe kwamangqamuzana futhi i-immunotherapy manje seziyizinsika ezimaphakathi. Izinqumo zokwelashwa azisasekelwe kuphela ku-histology (njenge-adenocarcinoma vs. squamous cell carcinoma) kodwa ziqhutshwa ukuguqulwa kofuzo okuthile. Lokhu kushintsha kwepharadigm kuqinisekisa ukuthi iziguli zithola izidakamizwa ezisebenza kahle kakhulu zebhayoloji yazo ethile yesimila.

Izinqubo Zokwelashwa Komdlavuza Wamaphaphu Esigaba Sasekuqaleni

Ezigulini ezitholwe zinomdlavuza weSigaba I kanye neSigaba II ongewona omncane wamaphaphu wamaphaphu (NSCLC), umgomo oyinhloko uwukwelapha. Imihlahlandlela yase-China yango-2026 iqinisekisa kabusha ukuthi ukuhlinzwa kabusha kuyindinganiso eyigolide kumakhandidethi asebenzayo. Kodwa-ke, indlela yokuhlinzwa kanye nokwelashwa kwe-adjuvant isiphenduke inkimbinkimbi ukuze kwandiswe ukuphila kwesikhathi eside.

Ukungenelela Kokuhlinzwa kanye Namasu Okuhlasela Kancane

Ukuhlinzwa kuseyindlela ephumelela kakhulu yokususa izimila ezisaqala. Ezikhungweni zezokwelapha ezinkulu zaseShayina, Ukuhlinzwa Kwethoracoscopic Okusizwa Ngevidiyo (i-VATS) kanye Nokuhlinzwa Kwethoracic Okusizwa ngeRobot sekuyinto evamile. Lezi zindlela zokuhlasela kancane zinciphisa isikhathi sokutakula kanye nezinkinga uma kuqhathaniswa ne-thoracotomy yendabuko evulekile.

• I-Lobectomy: Ukususwa kwayo yonke i-lobe yephaphu kuyinqubo evamile ezimweni eziningi zeSigaba I kanye nesesi-II.
• I-Segmentectomy: Kumathumba amancane noma iziguli ezinomkhawulo wokusebenza kwamaphaphu, ukususa ingxenye kuphela ye-lobe kuya ngokuya kwamukelwa.
• Ukuhlukaniswa kwe-lymph node: Ukusampula okuhlelekile noma ukuhlukaniswa kwama-lymph nodes e-mediastinal kuyisibopho ukuze kube nesiteji esinembile nokulawula kwendawo.

I-Adjuvant Therapy Strategies

Ukwelashwa kwangemva kokuhlinzwa, okwaziwa ngokuthi i-adjuvant therapy, kubalulekile ekuqedeni izifo ezincane kakhulu nokuvimbela ukuphindeka. Imihlahlandlela yango-2026 inikeza izincomo ezibuyekeziwe ezisuselwe ezivivinyweni zakamuva zomtholampilo.

Ezigulini zeSigaba IB kuya ku-III ezinezinguquko ezithile zofuzo, njenge-EGFR positivity, i-adjuvant target therapy manje isinconywe kakhulu. Lokhu kubonisa intuthuko enkulu eminyakeni edlule lapho i-chemotherapy yayiwukuphela kwenketho. Ngokufanayo, ezigulini ezingenazo izinguquko zomshayeli kodwa ezinenkulumo ephezulu ye-PD-L1, i-adjuvant immunotherapy ingasetshenziswa ngemva kwe-chemotherapy-based chemotherapy.

Ukuphatha Umdlavuza Wamaphaphu Okuthuthukisiwe endaweni

Isigaba sesi-III somdlavuza wamaphaphu siveza isimo somtholampilo esiyinkimbinkimbi lapho lesi sifo sesisakazekele kuma-lymph node aseduze kodwa hhayi ezithweni ezikude. Lesi sigaba sivame ukubizwa ngokuthi "esithuthukisiwe endaweni." Indlela yokwelapha idinga ithimba lezinhlaka eziningi elibandakanya odokotela abahlinzayo, odokotela be-oncologist bezokwelapha, nama-oncologists emisebe.

Iqhaza Le-Multimodal Therapy

Isisekelo sokwelashwa kweSigaba III yi ukwelashwa kwe-multimodal, ehlanganisa izindlela ezahlukene zokwelapha. Ukulandelana okuqondile kuncike ekutheni isimila sithathwa njengesikhiphekayo yini.

• Isigaba sesi-III esingahlehliswa kabusha: Iziguli zingase zithole ukwelashwa kwe-neoadjuvant (i-chemotherapy noma i-chemo-immunotherapy) ukuze kuncishiswe isimila ngaphambi kokuhlinzwa. Ngemuva kokuhlinzwa, ukwelashwa okungeziwe kwe-adjuvant kunikezwa.
• Isigaba III esingenakuvinjelwa: Ezigulini ezingakwazi ukuhlinzwa ngenxa yendawo yesimila noma isimo sezempilo, i-chemoradiotherapy (cCRT) iyindinganiso yokunakekelwa.

Ukuhlanganiswa kwe-Immunotherapy

Impumelelo ekulawuleni isifo seSigaba III esingenakuvinjelwa ukusetshenziswa kwe-consolidation immunotherapy. Ngemva kokuqeda i-chemoradiotherapy kanyekanye, iziguli ezingakathuthuki zelashwa ngama-immune checkpoint inhibitors. Imihlahlandlela yango-2026 igqamisa lelisu njengokungenelela okubalulekile okuthuthukise kakhulu ukusinda okungenanqubekelaphambili kanye namazinga okusinda esewonke kubantu baseShayina.

Isigaba IV Umdlavuza Wamaphaphu: I-Systemic Treatment Revolution

Isigaba IV, noma umdlavuza wamaphaphu we-metastatic, senzeka lapho lesi sifo sisakazekela ezithweni ezikude njengobuchopho, amathambo, isibindi, noma elinye iphaphu. Ngokomlando, ukubikezelwa kweSigaba IV kwakungekuhle, izikhathi zokusinda zemvelo zisukela ezinyangeni ezi-1 kuye kwezingu-3 kuphela. Nokho, i 2026 Izinkombandlela Zokwelashwa KwaseShayina khombisa uguquko olumangalisayo emiphumeleni ngenxa yokuthuthuka kwezindlela zokwelapha ezihlelekile.

Ukuhlolwa Kwemolekyuli Njengemfuneko

Ngaphambi kokuqala noma yikuphi ukwelashwa kweSigaba IV NSCLC, ukuhlolwa kwamangqamuzana okuphelele kuyadingeka. Imihlahlandlela igcizelela ukuthi i-tissue biopsy noma i-liquid biopsy (ukuhlolwa kwegazi) kufanele kwenziwe ukuze kutholwe ukuguqulwa komshayeli. Okuhlosiwe okujwayelekile kufaka i-EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, kanye ne-NTRK.

Kungani ukuhlola kubalulekile: Ukuhlonza ukuguqulwa okuthile kuvumela odokotela ukuba banikeze imithi yomlomo ehlosiwe esebenza kahle kakhulu futhi engenabuthi obuncane kunokwelapha ngamakhemikhali endabuko. Ezigulini ezingenazo izinguquko ezingenzeka, ukuhlolwa kwe-PD-L1 kuqondisa ukusetshenziswa kwe-immunotherapy.

Izinketho Zokwelapha Eziqondisiwe

Isibuyekezo sika-2026 sihlanganisa yonke imithi emisha egunyazwe i-National Medical Products Administration (NMPA) yase-China kuze kube sekupheleni kuka-2025. Lokhu kufaka phakathi isizukulwane sesithathu se-EGFR inhibitors kanye nesizukulwane esilandelayo se-ALK inhibitors esinamandla aphakeme okungena kumgoqo wegazi nobuchopho.

• Ukuguqulwa kwe-EGFR: Ukwelashwa komugqa wokuqala ngokuvamile kuhilela isizukulwane sesithathu se-tyrosine kinase inhibitors (TKIs). Le mithi ibonise ukusebenza kahle okuphakeme ekulawuleni kokubili isifo se-intrathoracic kanye nama-metastases ebuchosheni.
• Ukuhlelwa kabusha kwe-ALK: Ama-ALK inhibitors anamandla manje aseyindinganiso, enikeza ukulawulwa kwezifo isikhathi eside namazinga aphezulu okuphendula.
• Okunye Okuqondisiwe: Ama-Specific inhibitors ayatholakala ku-ROS1, BRAF V600E, MET exon 14 skipping, kanye ne-RET fusion positives.

Immunotherapy Inhlanganisela

Ezigulini ezintula ukuguqulwa komshayeli, i-immunotherapy ehlanganiswe ne-chemotherapy isiphenduke indinganiso entsha. Imihlahlandlela incoma izinhlobo ezahlukene zemithi ezisuselwe kuhlobo oluncane lwe-histological (i-squamous vs. non-squamous) kanye namaleveli wokusho we-PD-L1. Ezimeni zokuvezwa okuphezulu kwe-PD-L1, i-immunotherapy monotherapy ingase ibhekwe ukuze isindise iziguli ebusheni be-chemotherapy.

Ukugxila Okukhethekile: I-Metastases yobuchopho bomdlavuza wamaphaphu

Ama-metastases ebuchosheni ayinkinga evamile futhi enzima yomdlavuza wamaphaphu, ethinta ingxenye enkulu yeziguli zeSigaba IV. NgoJanuwari 2026, iChina yakhulula abazinikele "Iziqondiso Zokwelashwa KwaseShayina Zomdlavuza Wamaphaphu Metastases (Ushicilelo luka-2026)". Lo mbhalo ukhuluma ngezinselelo ezithile zokwelapha umdlavuza osusabalele ebuchosheni.

Amazinga Okuxilonga

Imihlahlandlela ikubeka ngokusobala lokho I-Magnetic Resonance Imaging (MRI) yekhanda iyindlela ethandwayo yokucabanga yokuxilonga nokuqapha ama-metastases obuchopho. Ama-CT scan awanele ukuthola izilonda ezincane. Ukuhlolwa kwe-MRI okuvamile kunconywa ezigulini ezisengozini enkulu ngisho nalapho kungabikho izimpawu zemizwa.

Ukuphathwa Kwabantu

Ukuphathwa kwe-metastase yobuchopho kudinga indlela ehambisanayo ehlanganisa izindlela zokwelapha zendawo nezesistimu:

• Ukwelashwa Kwesistimu: Izidakamizwa eziqondiswe esizukulwaneni esisha ezinomkhawulo ophezulu wegazi nobuchopho bokungena ngokuvamile ziwumugqa wokuqala wokuzivikela ezigulini ezinokushintshwa komshayeli. Bangakwazi ukuncipha izilonda zobuchopho ngempumelelo ngaphandle kwesidingo esisheshayo semisebe.
• I-Radiosurgery: I-Stereotactic Radiosurgery (SRS) ikhethwa ezinambeni ezilinganiselwe zama-metastases. Iletha imisebe yomthamo omkhulu ngokunembile esimila kuyilapho isindisa izicubu zobuchopho ezinempilo.
• I-Whole Brain Radiation Therapy (WBRT): Igcinelwe iziguli ezine-metastase eminingi noma isifo se-leptomeningeal, nakuba kwenziwa imizamo yokunciphisa imiphumela engemihle yengqondo.
• I-Neurosurgery: Ukukhishwa kabusha kokuhlinzwa kucatshangelwa izilonda ezinkulu, eziyizimpawu ezibangela umphumela omkhulu noma ngezinjongo zokuxilonga lapho isimila esiyinhloko singaziwa.

Izivumelwano Zomdlavuza Wamaphaphu Amancane (SCLC).

Nakuba Umdlavuza Ongewona Owomncane Wengqamuzana Wamaphaphu (NSCLC) uthatha cishe u-85% wamacala, Umdlavuza Weseli Encane Wamaphaphu (SCLC) uluhlobo oluncane oluhlukile futhi olunolaka. Imihlahlandlela yango-2026 igcina indlela ehlukile ye-SCLC ngenxa yokukhula kwayo ngokushesha kanye ne-metastasis yokuqala.

Isiteji Esinomkhawulo vs. Isiteji Esibanzi

I-SCLC ihlukaniswe kabanzi ku-Limited Stage (evalelwe ku-hemithorax eyodwa) kanye ne-Extensive Stage (sabalala ngaphesheya).

• Isiteji Esinomkhawulo: Izinga lokunakekelwa i-chemoradiotherapy kanyekanye. I-Prophylactic cranial irradiation (PCI) ingase icatshangelwe kubaphenduli ukuvimbela ama-metastases ebuchosheni.
• Isiteji Esibanzi: Ukwelashwa kuhilela i-systemic chemotherapy ehlanganiswe ne-immunotherapy. Ukwengezwa kwama-immune checkpoint inhibitors ku-platinum-etoposide chemotherapy sekuphenduke indinganiso yomhlaba wonke neyamaShayina, okwenza ngcono ukusinda sekukonke.

Izindleko Zokwelashwa Komdlavuza Wamaphaphu e-China

Ukuqonda isici sezezimali kubalulekile ezigulini ezifunayo ukwelashwa komdlavuza wamaphaphu ngesiteji eChina. Izindleko ziyahlukahluka ngokuya ngesiteji, indlela yokwelashwa, izinga lesibhedlela, kanye nokuhlinzekwa komshwalense. Uhlelo lukazwelonke lokunakekelwa kwezempilo lwaseChina selwenze inqubekelaphambili enkulu ekwehliseni umthwalo wesiguli ngoHlelo Lukazwelonke Lokubuyisela Izidakamizwa (NRDL).

Ukwehlukaniswa Kwezindleko Zokwelashwa

Izindleko ngokuvamile ziphansi e-China uma kuqhathaniswa namazwe aseNtshonalanga, ikakhulukazi emithini emisha efakwe ohlelweni lomshwalense kazwelonke.

• Ukuhlinzwa: I-lobectomy ehlasela kancane ngokuvamile isukela ku-40,000 kuya ku-80,000 RMB ($5,500 – $11,000 USD), kuye ngobunkimbinkimbi nezinga lesibhedlela. Umshwalense uhlanganisa ingxenye enkulu.
• I-Chemotherapy: Imithi yendabuko yokwelapha ngamakhemikhali ithengeka kakhulu, ngokuvamile ibiza izinkulungwane ezimbalwa ze-RMB ngomjikelezo ngamunye ngemva kokubuyiselwa.
• Ukwelapha Okuhlosiwe: Ngaphambi kokufakwa ku-NRDL, le mithi ibimba eqolo. Manje, ama-TKI amaningi abalulekile asemboziwe, kunciphisa izindleko zenyanga eziphuma ephaketheni zibe phakathi kuka-2,000 no-5,000 RMB ($280 – $700 USD) ezigulini eziningi.
• I-Immunotherapy: Ama-Domestic PD-1 inhibitor awabizi kakhulu, kanti eminye imijikelezo ibiza kancane njengokungu-3,000 RMB ($420 USD) ngemva komshwalense. Izidakamizwa ezingenisiwe zingaba phezulu kancane kodwa ziya ngokuya zifinyeleleka.
• Ukwelapha ngemisebe: Izifundo ze-IMRT noma ze-SBRT ngokuvamile zisukela ku-20,000 kuye ku-50,000 RMB ($2,800 – $7,000 USD).

Umshwalense Nokungeneka

Uhlelo Lomshwalense Wezempilo Oyisisekelo eShayina luhlanganisa inqwaba yemithi elwa nomdlavuza. Imihlahlandlela yango-2026 ibhekisisa ukutholakala kwezidakamizwa kanye nesimo sembuyiselo lapho kwenziwa izincomo. Iziguli zelulekwa ukuthi zithintane nosonhlalakahle basesibhedlela noma ochwepheshe bomshuwalense ukuze kwandiswe izinzuzo zazo. Ukwengeza, umshwalense owengeziwe wezohwebo kanye nezinhlelo zokusiza abampofu ziqhubekisela phambili ukudambisa ubuthi bezezimali emindenini.

Ukuthola Izibhedlela Nongoti Eduze Kwakho

Ukuthola ukunakekelwa kwekhwalithi ephezulu kubalulekile ukuze kube nemiphumela emihle. I-China inezikhungo eziningi zomdlavuza ezisezingeni lomhlaba ezihola ocwaningweni nasekusetshenzisweni komtholampilo kwemihlahlandlela ka-2026. Uma usesha izibhedlela eziseduze kwami, iziguli kufanele zibheke izikhungo ezineminyango ekhethekile ye-thoracic oncology.

Izikhungo eziphezulu ze-Oncology

Izibhedlela ezithile e-China ziyaziwa kuzwelonke ngobuchwepheshe bazo ekulawulweni komdlavuza wamaphaphu:

• Isibhedlela somdlavuza, i-Chinese Academy of Medical Science (Beijing): Umholi ekwakhiweni komhlahlandlela kazwelonke kanye nokuphathwa kwamacala ayinkimbinkimbi.
• I-Fudan University Shanghai Cancer Centre: Idume ngendlela yayo edidiyelwe kanye namasu okuhlinza athuthukile.
• Isibhedlela sase-Peking Union Medical College: Inikeza amaqembu abanzi emikhakha eminingi ehlanganisa i-neurosurgery ye-metastases yobuchopho.
• Isibhedlela sase-West China (Sichuan University): Isizinda esikhulu sasentshonalanga yeChina, esihlinzeka ngemisebe esezingeni eliphezulu kanye ne-oncology yezokwelapha.

Indlela Yokukhetha Isikhungo Esilungile

Lapho ukhetha isibhedlela, cabangela izici ezilandelayo:

• Ithimba le-Multidisciplinary Team (MDT): Qinisekisa ukuthi isibhedlela sibamba imihlangano ye-MDT evamile lapho odokotela abahlinzayo, izazi ze-oncologists, kanye nodokotela be-radioologists besebenzisana necala lakho.
• Amakhono e-Pathology kanye neGenetics: Isikhungo kumele sibe namalebhu athuthukile okuhlolwa kwamangqamuzana okusheshayo nokunembile.
• Ukufinyelela Kwesivivinyo Somtholampilo: Izibhedlela eziphezulu zivame ukunikeza ukufinyelela ezinhlolweni zakamuva zemitholampilo ezigulini esezikhathele izinketho ezijwayelekile.
• Amasevisi Osekelo: Bheka izibhedlela ezinikeza ukwesekwa kokudla okunomsoco, ukuphathwa kwezinhlungu, nokwelulekwa ngokwengqondo.

Ukuhlaziywa Okuqhathaniswayo Kwezindlela Zokwelapha

Ukuze uqonde kangcono izinketho ezitholakala ngaphansi kwemihlahlandlela yango-2026, ithebula elilandelayo liqhathanisa izindlela zokwelapha eziyinhloko ezisetshenziswa e-China namuhla.

Isinyathelo Ngesinyathelo Uhambo Lwesiguli ngo-2026

Ukuzulazula ohlelweni lokunakekelwa kwezempilo kungase kube nzima. Ngezansi kuyindlela eqondile yesiguli okusolwa ukuthi sinomdlavuza wamaphaphu e-China, ehambisana neziqondiso zakamuva.

• Isinyathelo 1: Ukuhlola kanye Nokuxilongwa: Abantu abasengozini enkulu (abaneminyaka engu-50+, ababhemayo) bathola i-Low-Dose Spiral CT (LDCT). Uma i-nodule itholakala, ukuthwebula okwengeziwe kanye ne-biopsy kwenziwa.
• Isinyathelo sesi-2: Ukusebenza kwesiteji: Uma umdlavuza usuqinisekisiwe, i-PET-CT, i-MRI yobuchopho, nezikena zamathambo zenziwa ukuze kutholwe isigaba se-TNM.
• Isinyathelo sesi-3: Iphrofayela ye-Molecular: Izicubu noma amasampula egazi athunyelwa ukuze kuhlolwe izakhi zofuzo ukuze kuhlonzwe ukuguqulwa kwezakhi ezifana ne-EGFR noma i-ALK.
• Isinyathelo sesi-4: Ingxoxo Yemikhakha Ehlukahlukene: Ithimba le-MDT libuyekeza yonke idatha ukuze lenze uhlelo lokwelapha lomuntu siqu olusekelwe kuzinkombandlela zika-2026.
• Isinyathelo sesi-5: Ukuqaliswa Kokwelashwa: Ukwelashwa kuqala (ukuhlinzwa, izidakamizwa, noma imisebe). Ukuqapha eduze kwemiphumela emibi kuqaliswa ngokushesha.
• Isinyathelo sesi-6: Ukulandelela Nokugada: Ukuthwebula okujwayelekile nokuhlolwa kwegazi kuqapha impendulo. Ukwelashwa kuyalungiswa uma ukukhula noma ukumelana kwenzeka.

Izinzuzo kanye Nezinselelo Zezinqubo Zamanje

Ukuqaliswa kwemihlahlandlela yango-2026 kuletha izinzuzo ezibalulekile kodwa futhi kuveza izinselele ezithile iziguli nabahlinzeki okufanele bazizuzise.

Amandla endlela ka-2026

• Ukwenza kube ngokwakho: Ukwelashwa kwenzelwe ukwakheka kofuzo lomuntu, okwandisa ukusebenza kahle.
• Ukusinda Okuthuthukisiwe: Ukuhlanganiswa kwemithi emisha kuye kwandise ngokusobala iminyaka yokuphila yeziguli zeSigaba IV.
• Ikhwalithi Yempilo: Izindlela zokwelapha ezihlosiwe kanye ne-immunotherapies ngokuvamile zinemiphumela emibi embalwa kune-chemotherapy yendabuko.
• Ukumisa: Imihlahlandlela kazwelonke ebumbene iqinisekisa ukuthi iziguli ezifundeni ezihlukene zithola ukunakekelwa okungaguquki, okuseqophelweni eliphezulu.

Izindawo Zokuthuthukisa

• Izilinganiso Zokutholwa Kusenesikhathi: Naphezu kwemihlahlandlela, iziguli eziningi zisenezifo ezifika sekwephuzile ngenxa yokubamba iqhaza okuphansi kokuhlolwa.
• Ukumelana Nezidakamizwa: Amathumba agcina ekwazi ukumelana nemithi ehlosiwe, okudinga amasu ayinkimbinkimbi omugqa wesibili.
• Ukungafani Kwesifunda: Ukufinyelela ekuhlolweni kofuzo okuthuthukisiwe kanye nemithi emisha kungahluka phakathi kwamadolobha asezingeni eliphezulu nezindawo zasemakhaya.
• Ukuphathwa Kwemiphumela Emibi: Nakuba ithuthukisiwe, izehlakalo ezimbi ezihlobene nokuzivikela komzimba zidinga ubuchwepheshe bokuphatha obukhethekile.

Ukubaluleka Kokuhlolwa Kusenesikhathi

Imihlahlandlela yango-2026 igcizelela kakhulu ukuvikela nokutholwa kusenesikhathi. IKhomishana Yezempilo Kazwelonke ikhiphe izikimu eziqondile zokuhlola umdlavuza wamaphaphu, okubhekiswe kubantu abasengozini enkulu. Ukutholwa kusenesikhathi kuseyindlela eyodwa ephumelela kakhulu yokuthuthukisa izinga lokusinda leminyaka emi-5.

Ubani Okufanele Ahlolwe?

Ukuhlolwa kunconyiwe kubantu abaneminyaka engama-50 kuye kwengama-74 abahlangabezana okungenani nenqubo eyodwa kwezilandelayo:

• Umlando wokubhema weminyaka engu-≥20 wephakethe (okuhlanganisa ababekade bebhema abayeka ngaphansi kweminyaka eyi-15 edlule).
• Ukuchayeka isikhathi eside kugwayi kagwayi (ukuphila noma ukusebenza nababhemi iminyaka engu-≥20).
• Umlando Wezifo Ezingalapheki Ezivimbela Amaphaphu (COPD).
• Ukuchayeka emsebenzini kuma-carcinogens afana ne-asbestos, i-radon, noma izinsimbi ezisindayo.
• Umlando womndeni womdlavuza wamaphaphu ezihlotsheni ze-first degree.

Indlela Yokuhlola Enconyiwe

I-Low-Dose Spiral CT (LDCT) ukuphela kwendlela yokuhlola enconyiwe. Ama-X-ray esifuba adikibala ngokusobala njengoba egeja amaqhuqhuva asekuqaleni. Imihlahlandlela icacisa ukuthi i-LDCT kufanele yenziwe kusetshenziswa izikena ezinemigqa okungenani engu-16 yomtshina, ehunyushwa ochwepheshe be-radiologist abanolwazi.

Izikhombisi-ndlela Zesikhathi esizayo kanye Nemithi Yokwelapha Esafufusa

Njengoba sithuthuka ngo-2026, inkambu yokwelashwa komdlavuza wamaphaphu iyaqhubeka nokuvela ngokushesha. Ucwaningo lugxile ekunqobeni ukumelana nemithi, ukuhlanganisa izindlela zokwelapha zemiphumela ye-synergistic, kanye nokwakha imithi yokugoma.

Ama-antibody-drug conjugates (ADCs) avela njengesigaba esisha esinamandla sezidakamizwa, abonisa isithembiso ezigulini ezihlulekile emithini yokwelapha eqondisiwe yangaphambilini. Ngaphezu kwalokho, ubuhlakani bokwenziwa buya ngokuya buhlanganiswa ku-radiology ukuze kutholwe izigaxana ngaphambi kwesikhathi nokubikezela izimpendulo zokwelashwa ngokunembe kakhudlwana.

Ukuzinikela kwezinhlangano zezokwelapha zaseShayina ekubuyekezeni njalo imihlahlandlela kuqinisekisa ukuthi iziguli ziyahlomula ekuthuthukisweni kwakamuva kwesayensi ngaphandle kokulibala. Ukusebenzisana phakathi kwezinkampani ezikhiqiza imithi yasekhaya kanye nezinhlangano zocwaningo emhlabeni wonke kusheshisa ukutholakala kwemithi emisha ngaphakathi kwe-China.

Isiphetho

Indawo ye ukwelashwa komdlavuza wamaphaphu ngesiteji ngo-2026 kuchazwa ngokunemba, ukwenza kube ngokwakho, kanye nethemba. Ukukhululwa kwe- 2026 Izinkombandlela Zokwelashwa KwaseShayina kuphawula ingqopha-mlando ebalulekile, ehlanganisa iminyaka yocwaningo emikhondo yomtholampilo engasebenza. Kusukela emandleni okwelapha okuhlinzwa ezigabeni zokuqala kuya emandleni okwandisa impilo yokwelashwa okuqondiwe kanye nokwelashwa kwamasosha omzimba eSigabeni IV, iziguli namuhla zinezinketho eziningi kunangaphambili.

Nakuba izinselele ezifana namazinga okutholwa kusenesikhathi kanye nokumelana nezidakamizwa ziqhubeka, indlela ehlelekile ekhuthazwa odokotela be-oncologist baseShayina abaphambili inikeza uhlaka oluqinile lokunakekelwa. Ngokusebenzisa ukuxilonga okuthuthukile, ukunamathela ezivumelwaneni ezijwayelekile, nokusebenzisa ukwesekwa okuphelele kohlelo lwezempilo lukazwelonke, ukubikezelwa kweziguli ezinomdlavuza wamaphaphu eChina kuyaqhubeka nokuba ngcono. Kunoma ubani othintwe yilesi sifo, ukuqonda lezi zigaba kanye nokwelashwa okutholakalayo kuyisinyathelo sokuqala sokuzulazula ohambweni ngokuzethemba nokufinyelela ekunakekelweni okungcono kakhulu.